This week, seven Health Care Provider stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
Express Scripts (NASDAQ:ESRX) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. Express Scripts Holding is a full service pharmacy benefit management and specialty managed care company serving clients throughout North America. In Portfolio Grader’s specific subcategory of Sales Growth, ESRX also gets an A. Shares of ESRX have increased 7.5% over the past month, better than the 4% increase the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of ESRX stock.
Molina Healthcare (NYSE:MOH) boosts its rating from a C to a B this week. Molina Healthcare is a multi-state managed care organization that participates in government-sponsored health care programs such as Medicaid and the Children’s Health Insurance Program. For more information, get Portfolio Grader’s complete analysis of MOH stock.
Gentiva Health Services (NASDAQ:GTIV) is seeing ratings go up from a C last week to a B this week. Gentiva Health Services provides comprehensive home health services, including hospice, respiratory and home medical equipment, infusion therapy services and consulting, throughout most of the United States. Investors have pushed the stock price up 45.3% over the past month. For more information, get Portfolio Grader’s complete analysis of GTIV stock.
This week, MWI Veterinary Supply (NASDAQ:MWIV) pushes up from a C to a B rating. MWI Veterinary Supply distributes animal health products to veterinarians across the United States. For more information, get Portfolio Grader’s complete analysis of MWIV stock.
BioScrip (NASDAQ:BIOS) earns a B this week, jumping up from last week’s grade of C. BioScrip provides pharmacy and home health services in the United States. The stock currently has a trailing PE Ratio of 5.4. For more information, get Portfolio Grader’s complete analysis of BIOS stock.
This is a strong week for National Healthcare (AMEX:NHC). The company’s rating climbs to B from the previous week’s C. National Healthcare operates long-term health care centers. For more information, get Portfolio Grader’s complete analysis of NHC stock.
National Research Corp. (NASDAQ:NRCI) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. National Research provides ongoing survey-based performance measurement, analysis, and tracking services to the healthcare industry. For more information, get Portfolio Grader’s complete analysis of NRCI stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.